Skip to main content

Table 1 Patient’s characteristics

From: Reduced fractional shortening of right ventricular outflow tract is associated with adverse outcomes in patients with left ventricular dysfunction

Age, years 62 ± 17
Sex Male (79%)
NYHA functional class III-IV 17 (21%)
  (I 31; II 33; III 15; IV 2)  
Etiology  
IHD 22 (27%)
Non-IHD 59 (73%)
  Valvular disease 4 (5%)
  DCM 37 (46%)
   HCM 5 (6%)
   HHD 7 (9%)
   Others 6 (7%)
Electrocardiogram  
  Sinus rhythm 54 (67%)
  Atrial fibrillation 19 (23%)
  Pacing rhythm 8 (10%)
Medications  
  Beta-blocker 62 (78%)
  ACE-I/ARB 65 (80%)
  Calcium channel blocker 16 (20%)
  Diuretic 61 (75%)
  Aldosterone antagonist 47 (58%)
Laboratory test  
  BNP (pg/mL) 765 ± 870
  Uric acid (mg/dL) 7.4 ± 2.6
  Hemoglobin (g/dL) 14.0 ± 2.1
  Total bilirubin (mg/dL) 1.1 ± 0.8
  C-reactive protein (mg/dL) 1.5 ± 2.9
 eGFR (mL/min/1.73 m2) 51 ± 20
Echocardiographic examination  
  LAD (cm) 4.1 ± 0.8
  IVSTd (cm) 1.0 ± 0.3
  LVPWTd (cm) 1.1 ± 0.3
  LVDd (cm) 6.1 ± 1.0
  LVDs (cm) 5.4 ± 1.1
  LVEF (%) 30 ± 8
  RVFAC (%) 35 ± 14
  TR-PG (mmHg) 25 ± 12
  1. Values are expressed as absolute numbers (%) or the mean ± SD.
  2. NYHA New York Heart Association, IHD ischemic heart disease, DCM dilated cardiomyopathy, HCM hypertrophic cardiomyopathy, HHD hypertensive heart disease, Others include 2 sarcoidosis, 1 LV noncompaction, 1 restrictive cardiomyopathy and 2 unknown origin, ACE-I angiotensin converting enzyme inhibitor, ARB angiotensin II type 1 receptor antagonist, BNP brain natriuretic peptide, eGFR estimated glomerular filtration rate, LAD left atrial dimension (diastole), IVSd intraventricular septal wall thickness (diastole), LVPWTd left ventricular posterior wall thickness (diastole), LVEF left ventricular ejection fraction, RVFAC right ventricular fractional area change, TR-PG tricuspid regurgitation-pressure gradient.